This Article Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Sever, P. Search for Related Content PubMed PubMed Citation Articles by Sever, P. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Blood Pressure Medicines Clinical Trials Social Bookmarking                         What's this?

ASCOT a Four Horse Race

NHLI Division Imperial College London International Centre for Circulatory Health, 59-61 North Wharf Road, London, W2 1NY, UK, p.sever{at}imperial.ac.uk

References

• Dahlöf B., Sever PS, Poulter NR et al; for the ASCOT Investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005;366:895-906.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Poulter NR, Wedel H., Dahlöf B. et al; for the ASCOT Investigators Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA). Lancet 2005;366:907-13[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Furberg CD, Psaty BM Should calcium antagonists be first-line agents in the treatment of cardiovascular disease? The public health perspective. Cardiovasc Drugs Ther 1996; 10:463-6.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Sever PS, Dahlöf B., Poulter NR et al; for the ASCOT investigators. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial - Lipid lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 2003;361:1149-58.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Williams B., Poulter NR, Brown MJ et al; BHS guidelines working party, for the British Hypertension Society. British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary. BMJ 2004;328:634-40.[Free Full Text]
• Hypertension Detection and Follow-up Programme Cooperative Group (HDFP). Five-year findings of the Hypertension Detection and Follow-up Programme: reduction in mortality in persons with high blood pressure, including mild hypertension. JAMA 1979;242:2562-571.[Abstract/Free Full Text]
• Heart Outcomes Prevention Evaluation Study Investigators (HOPE). Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 2000;355:253-9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Williams B. The renin angiotensin system and cardiovascular disease: hope or hype? JRAAS 2000;2:142-6.
• Staessen JA, Thijs L., Birkenhager WH Evidence that new antihypertensives are superior to older drugs. Lancet 2005; 366:869-70.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Staessen JA, Li Y., Thijs L., Wang JG Blood pressure reduction and cardiovascular prevention: an update including the 2003-2004 secondary prevention trials. Hypertens Res 2005;28:385-407.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic. JAMA 2002;23:2981-97.
• Julius S., Kjeldsen SE, Weber M. et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet 2004;363:2022-31.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Journal of Renin-Angiotensin-Aldosterone System, Vol. 6, No. 2, 51-54 (2005)
DOI: 10.3317/jraas.2005.010


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Sever, P. Search for Related Content PubMed PubMed Citation Articles by Sever, P. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Blood Pressure Medicines Clinical Trials Social Bookmarking                         What's this?